BioMaxima Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for BioMaxima.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 18.1% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Jun 08
BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Apr 21Returns On Capital Are Showing Encouraging Signs At BioMaxima (WSE:BMX)
Sep 07BioMaxima (WSE:BMX) Seems To Use Debt Quite Sensibly
Mar 07We Think BioMaxima (WSE:BMX) Might Have The DNA Of A Multi-Bagger
Feb 02BioMaxima (WSE:BMX) Knows How To Allocate Capital Effectively
Sep 06We Think BioMaxima (WSE:BMX) Can Stay On Top Of Its Debt
Jun 04Does BioMaxima (WSE:BMX) Have A Healthy Balance Sheet?
Feb 18Are BioMaxima's (WSE:BMX) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 14
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as BioMaxima has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2024 | 47 | 0 | -11 | 5 | N/A |
| 12/31/2023 | 47 | 1 | -16 | 2 | N/A |
| 9/30/2023 | 47 | 1 | -18 | 1 | N/A |
| 6/30/2023 | 48 | 2 | -21 | -3 | N/A |
| 3/31/2023 | 61 | 5 | -6 | 5 | N/A |
| 12/31/2022 | 144 | 29 | 27 | 37 | N/A |
| 9/30/2022 | 154 | 31 | 26 | 30 | N/A |
| 6/30/2022 | 155 | 31 | 29 | 32 | N/A |
| 3/31/2022 | 146 | 28 | 19 | 23 | N/A |
| 12/31/2021 | 79 | 10 | -5 | 0 | N/A |
| 9/30/2021 | 79 | 12 | 3 | 8 | N/A |
| 6/30/2021 | 79 | 12 | 7 | 11 | N/A |
| 3/31/2021 | 81 | 14 | 5 | 8 | N/A |
| 12/31/2020 | 61 | 8 | 2 | 4 | N/A |
| 9/30/2020 | 46 | 5 | 3 | 5 | N/A |
| 6/30/2020 | 39 | 3 | 0 | 1 | N/A |
| 3/31/2020 | 30 | 1 | 4 | 5 | N/A |
| 12/31/2019 | 31 | 0 | 3 | 5 | N/A |
| 9/30/2019 | 31 | -1 | -3 | -1 | N/A |
| 6/30/2019 | 31 | -2 | -9 | -1 | N/A |
| 3/31/2019 | 32 | -1 | -14 | 3 | N/A |
| 12/31/2018 | 32 | 0 | -15 | 2 | N/A |
| 9/30/2018 | 32 | 0 | -10 | 7 | N/A |
| 6/30/2018 | 33 | 1 | -5 | 7 | N/A |
| 3/31/2018 | 33 | 1 | -1 | 2 | N/A |
| 12/31/2017 | 33 | 1 | N/A | 2 | N/A |
| 9/30/2017 | 36 | 1 | N/A | 1 | N/A |
| 6/30/2017 | 33 | 1 | N/A | 1 | N/A |
| 3/31/2017 | 30 | 1 | N/A | 1 | N/A |
| 12/31/2016 | 29 | 1 | N/A | 2 | N/A |
| 9/30/2016 | 24 | 1 | N/A | 2 | N/A |
| 6/30/2016 | 24 | 1 | N/A | 2 | N/A |
| 3/31/2016 | 24 | 1 | N/A | 3 | N/A |
| 12/31/2015 | 23 | 1 | N/A | 2 | N/A |
| 9/30/2015 | 22 | 1 | N/A | 1 | N/A |
| 6/30/2015 | 22 | 1 | N/A | 0 | N/A |
| 3/31/2015 | 21 | 1 | N/A | 0 | N/A |
| 12/31/2014 | 22 | 0 | N/A | 1 | N/A |
| 9/30/2014 | 24 | 1 | N/A | 1 | N/A |
| 6/30/2014 | 24 | 1 | N/A | 1 | N/A |
| 3/31/2014 | 23 | 1 | N/A | 2 | N/A |
| 12/31/2013 | 22 | 1 | N/A | 1 | N/A |
| 9/30/2013 | 29 | 2 | N/A | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BMX's forecast earnings growth is above the savings rate (3.7%).
Earnings vs Market: Insufficient data to determine if BMX's earnings are forecast to grow faster than the Polish market
High Growth Earnings: Insufficient data to determine if BMX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BMX's revenue is forecast to grow faster than the Polish market.
High Growth Revenue: Insufficient data to determine if BMX's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BMX's Return on Equity is forecast to be high in 3 years time